Tetsuya Maeda
Impact in
- Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
Papers in
- Neurology 48
- Parkinson's Disease Mechanisms and Treatments 40
- Neurological disorders and treatments 18
- Botulinum Toxin and Related Neurological Disorders 12
- Neurological Disease Mechanisms and Treatments 7
-
- Neurotransmitter Receptor Influence on Behavior 10
- Neuroscience and Neuropharmacology Research 7
- Co-authors
- Kazuya Kannari (12 shared papers)Masahiko Tomiyama (9 shared papers)Muneo Matsunaga (9 shared papers)Masaaki Hirayama (9 shared papers)Kinji Ohno (8 shared papers)Toshihiro Suda (5 shared papers)Hiroyasu Tanaka (5 shared papers)Ken Nagata (16 shared papers)
- Journals
- Journal of the Neurological Sciences (8 papers)Parkinsonism & Related Disorders (6 papers)Brain Research (4 papers)npj Parkinson s Disease (3 papers)Thrombosis Research (3 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Tetsuya Maeda
131 papers receiving 3.1k citations
Tetsuya Maeda's Hit Papers
Peers
Comparison fields: 5 of 138
- Neurology 1.2k
- Biological Psychiatry 182
- Cellular and Molecular Neuroscience 875
- Hepatology 355
- Neurology 207
Countries citing papers authored by Tetsuya Maeda
This map shows the geographic impact of Tetsuya Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Maeda more than expected).
Fields of papers citing papers by Tetsuya Maeda
This network shows the impact of papers produced by Tetsuya Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Maeda. The network helps show where Tetsuya Maeda may publish in the future.
Co-authors
The 25 scholars most cited alongside Tetsuya Maeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 270 | |
| 2 | 2005 | 257 | |
| 3 | 1999 | 254 | |
| 4 | 2017 | 208 | |
| 5 | 2005 | 109 | |
| 6 | 2020 | 95 | |
| 7 | 1999 | 91 | |
| 8 | [Tandospirone citrate, a selective 5-HT1A agonist, alleviates L-DOPA-induced dyskinesia in patients with Parkinson's disease]. | 2002 | 87 |
| 9 | 2022 | 77 | |
| 10 | Somatostatin receptors on human lymphocytes and leukaemia cells. | 1990 | 76 |
| 11 | 2000 | 75 | |
| 12 | 2003 | 73 | |
| 13 | 2016 | 68 | |
| 14 | 2003 | 68 | |
| 15 | 2021 | 67 | |
| 16 | 2005 | 62 | |
| 17 | 2012 | 62 | |
| 18 | 1999 | 47 | |
| 19 | 1991 | 44 | |
| 20 | 2017 | 43 |
About Tetsuya Maeda
Tetsuya Maeda is a scholar working on Neurology, Cellular and Molecular Neuroscience, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 148 papers that have together received 3.2k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (40 papers), Neurological disorders and treatments (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Botulinum Toxin and Related Neurological Disorders (12 papers), Neurotransmitter Receptor Influence on Behavior (10 papers), Neuroscience and Neuropharmacology Research (7 papers), Neurological Disease Mechanisms and Treatments (7 papers) and Dysphagia Assessment and Management (7 papers). The work is most often cited by research in Neurology (1.2k citations), Biological Psychiatry (182 citations), Cellular and Molecular Neuroscience (875 citations), Hepatology (355 citations) and Neurology (207 citations). Tetsuya Maeda has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kazuya Kannari, Masahiko Tomiyama, Muneo Matsunaga, Masaaki Hirayama, Kinji Ohno, Toshihiro Suda, Hiroyasu Tanaka, Ken Nagata, Yoshio Tsuboi and Kenichi Kashihara. Their work appears in journals such as Journal of the Neurological Sciences, Parkinsonism & Related Disorders, Brain Research, npj Parkinson s Disease and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.